We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Kingdom of fat middles

4 November 2019 By Robert Cyran

Pharmaceutical groups are racking up impressive growth in the world’s second-biggest market. Merck’s China sales increased 84% in the third quarter from a year earlier. Demographic forces and easier approvals outweigh forced price cuts. But domestic rivals will soon emerge.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)